ARTUSI, Carlo Alberto
ARTUSI, Carlo Alberto
NEUROSCIENZE "RITA LEVI MONTALCINI"
3 years comparison between duodopa and Deep Brain Stimulation
2012-01-01 Artusi, C.A.; Merola, A.; Zibetti, M.; Marchisio; Angrisano, S.; Rizzi, L.; Lanotte, M.M.; Rizzone, M.G.; Lopiano, L.
Atypical Presentation of Progressive Multifocal Leukoencephalopathy in a Natalizumab-treated Patient
2015-01-01 De Mercanti, S; Artusi, Ca; Clerico, M; Iudicello, M; Vacca, A; Virgilio, E; Durelli, L
Botulinum Toxin A for Treatment of Sialorrhea in neurologic diseases: 2-year Prospective Study
2015-01-01 Barbero, P; Artusi, Ca; De Mercanti, S; Tinivella, M; Busso, M; Clerico, M; Durelli, L
Clinical efficacy of different stimulation frequencies on dyskinesias and dystonias in subthalamic nucleus deep brain stimulation patients with parkinson's disease
2011-01-01 A. Merola; M.Zibetti; M. Rizzone; A. Marchisio; C.Artusi; N. Arduino; V. Ricchi; S. Angrisano; L.Rizzi; M. Lanotte; L. Lopiano
Continuous intraduodenal L-dopa/carbidopa gel infusion improves nocturnal sleep in advanced Parkinson’s disease
2012-01-01 M. Zibetti; M.G. Rizzone; V. Ricchi; A. Merola; S. Angrisano; A. Marchisio; C.A. Artusi; L. Rizzi; E. Montanaro; L. Lopiano
Cytomegalovirus Reactivation During Alemtuzumab Treatment for Multiple Sclerosis: A Case Report
2016-01-01 De Mercanti, S; Durelli, L; Iudicello, M; Artusi, Ca; Barbero, P; Guerrasio, A; Clerico, M
Cytomegalovirus reactivation during alemtuzumab treatment in a patient with multiple sclerosis
2016-01-01 De Mercanti, S.F.; Durelli, L.; Iudicello, M.; Artusi, C.A.; Barbero, P.; Guerrasio, A.; Clerico, M.
Effect of deep brain stimulation frequency on gait symmetry, smoothness and variability using IMU
2021-01-01 Panero E.; Digo E.; Dimanico U.; Artusi C. A.; Zibetti M.; Gastaldi L.
Effects of 80 Hz stimulation on gait in STN-DBS treated PD patients
2011-01-01 V Ricci; M Zibetti; A Merola; S Agrisano; M Rizzone; N. Arduino; CA Artusi; M Lanotte; L. Lopiano
Friedreich's ataxia patients and caregivers information seeking behaviour
2016-01-01 De Mercanti, S.; Barbero, P.; Iudicello, M.; Artusi, C.A.; Manera, U.; Durelli, L.; Clerico, M. .
How to treat patients after natalizumab discontinuation: the TY-STOP 2 study, an Italian, prospective and multicenter study
2017-01-01 Clerico, M; Signori, A; De Mercanti, S; Artusi, CA; Maniscalco, GT; Carotenuto, A; Lanzillo, R; Esposito, S; Capuano, R; Bonavita, S; Lorefice, L; Cocco, E; Annovazzi, P; Baroncini, D; Zaffaroni, M; Vercellino, M; Trebini, C; Cavalla, P; Clerici, VT; Bardina, V; Rolla, S; Durelli, L; Sormani, MP
Improving the care of Rebif® treated Multiple Sclerosis patients: the "MSdialog" experience
2016-01-01 Artusi, C.A.; De Mercanti, S.; Barbero, P.; Durelli, L.; Clerico, M.
Parkinson's clinical features after 30 years of disease: A study from patients treated by subthalamic nucleus stimulation
2011-01-01 A. Merola; M. Zibetti; M.G. Rizzone; V. Ricci; S. Agrisano; C.A. Artusi; N. Arduino; L. Rizzi; M.M. Lanotte; L. Lopiano
Peripheral neuropathy in Parkinson’s disease patients treated with duodenal levodopa/carbidopa infusion: A clinical and electrophysiological follow-up study
2012-01-01 A. Merola; M. Zibetti; N. Arduino; C.A. Artusi; A. Marchisio; Y. Falcone; M. Troiano; S. Angrisano; L. Rizzi; M.G. Rizzone; D. Cocito; L. Lopiano
Prospective assessment of peripheral neuropathy in duodopa treated patients
2012-01-01 C.A. Artusi; A. Merola; M. Zibetti; M. Rizzone; N. Arduino; M.Troiano; A. Marchisio; D. Cocito; L. Lopiano
The dominant subthalamic nucleus: A gait analysis study
2012-01-01 M.G. Rizzone; I. Carpinella; C.A. Artusi; M. Lanotte; L. Lopiano; A. Marchisio; A. Merola; M. Rabuffetti; D.V. Roccatagliata; M. Zibetti; M. Ferrarin
Ultrasound-guided botulinum toxin-A for sialorrhea: a 2-year prospective study
2015-01-01 Artusi, CA; De Mercanti, S; Busso, M; Tinivella, M; Clerico, M; Durelli, L; Barbero, P
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 3 years comparison between duodopa and Deep Brain Stimulation | 2012 | Artusi, C.A.; Merola, A.; Zibetti, M.; Marchisio; Angrisano, S.; Rizzi, L.; Lanotte, M.M.; Rizzone, M.G.; Lopiano, L. | |
| Atypical Presentation of Progressive Multifocal Leukoencephalopathy in a Natalizumab-treated Patient | 2015 | De Mercanti, S; Artusi, Ca; Clerico, M; Iudicello, M; Vacca, A; Virgilio, E; Durelli, L | |
| Botulinum Toxin A for Treatment of Sialorrhea in neurologic diseases: 2-year Prospective Study | 2015 | Barbero, P; Artusi, Ca; De Mercanti, S; Tinivella, M; Busso, M; Clerico, M; Durelli, L | |
| Clinical efficacy of different stimulation frequencies on dyskinesias and dystonias in subthalamic nucleus deep brain stimulation patients with parkinson's disease | 2011 | A. Merola; M.Zibetti; M. Rizzone; A. Marchisio; C.Artusi; N. Arduino; V. Ricchi; S. Angrisano; L.Rizzi; M. Lanotte; L. Lopiano | |
| Continuous intraduodenal L-dopa/carbidopa gel infusion improves nocturnal sleep in advanced Parkinson’s disease | 2012 | M. Zibetti; M.G. Rizzone; V. Ricchi; A. Merola; S. Angrisano; A. Marchisio; C.A. Artusi; L. Rizzi; E. Montanaro; L. Lopiano | |
| Cytomegalovirus Reactivation During Alemtuzumab Treatment for Multiple Sclerosis: A Case Report | 2016 | De Mercanti, S; Durelli, L; Iudicello, M; Artusi, Ca; Barbero, P; Guerrasio, A; Clerico, M | |
| Cytomegalovirus reactivation during alemtuzumab treatment in a patient with multiple sclerosis | 2016 | De Mercanti, S.F.; Durelli, L.; Iudicello, M.; Artusi, C.A.; Barbero, P.; Guerrasio, A.; Clerico, M. | |
| Effect of deep brain stimulation frequency on gait symmetry, smoothness and variability using IMU | 2021 | Panero E.; Digo E.; Dimanico U.; Artusi C. A.; Zibetti M.; Gastaldi L. | |
| Effects of 80 Hz stimulation on gait in STN-DBS treated PD patients | 2011 | V Ricci; M Zibetti; A Merola; S Agrisano; M Rizzone; N. Arduino; CA Artusi; M Lanotte; L. Lopiano | |
| Friedreich's ataxia patients and caregivers information seeking behaviour | 2016 | De Mercanti, S.; Barbero, P.; Iudicello, M.; Artusi, C.A.; Manera, U.; Durelli, L.; Clerico, M. . | |
| How to treat patients after natalizumab discontinuation: the TY-STOP 2 study, an Italian, prospective and multicenter study | 2017 | Clerico, M; Signori, A; De Mercanti, S; Artusi, CA; Maniscalco, GT; Carotenuto, A; Lanzillo, R; Esposito, S; Capuano, R; Bonavita, S; Lorefice, L; Cocco, E; Annovazzi, P; Baroncini, D; Zaffaroni, M; Vercellino, M; Trebini, C; Cavalla, P; Clerici, VT; Bardina, V; Rolla, S; Durelli, L; Sormani, MP | |
| Improving the care of Rebif® treated Multiple Sclerosis patients: the "MSdialog" experience | 2016 | Artusi, C.A.; De Mercanti, S.; Barbero, P.; Durelli, L.; Clerico, M. | |
| Parkinson's clinical features after 30 years of disease: A study from patients treated by subthalamic nucleus stimulation | 2011 | A. Merola; M. Zibetti; M.G. Rizzone; V. Ricci; S. Agrisano; C.A. Artusi; N. Arduino; L. Rizzi; M.M. Lanotte; L. Lopiano | |
| Peripheral neuropathy in Parkinson’s disease patients treated with duodenal levodopa/carbidopa infusion: A clinical and electrophysiological follow-up study | 2012 | A. Merola; M. Zibetti; N. Arduino; C.A. Artusi; A. Marchisio; Y. Falcone; M. Troiano; S. Angrisano; L. Rizzi; M.G. Rizzone; D. Cocito; L. Lopiano | |
| Prospective assessment of peripheral neuropathy in duodopa treated patients | 2012 | C.A. Artusi; A. Merola; M. Zibetti; M. Rizzone; N. Arduino; M.Troiano; A. Marchisio; D. Cocito; L. Lopiano | |
| The dominant subthalamic nucleus: A gait analysis study | 2012 | M.G. Rizzone; I. Carpinella; C.A. Artusi; M. Lanotte; L. Lopiano; A. Marchisio; A. Merola; M. Rabuffetti; D.V. Roccatagliata; M. Zibetti; M. Ferrarin | |
| Ultrasound-guided botulinum toxin-A for sialorrhea: a 2-year prospective study | 2015 | Artusi, CA; De Mercanti, S; Busso, M; Tinivella, M; Clerico, M; Durelli, L; Barbero, P |